- €193.54m
- €304.82m
- €186.73m
- 56
- 55
- 82
- 73
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24.7 | 103 | 187 | 161 | 187 |
Cost of Revenue | |||||
Gross Profit | 20.9 | 43.6 | 49.9 | 50.4 | 61.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15.3 | 73.5 | 158 | 136 | 164 |
Operating Profit | 9.41 | 29.5 | 29 | 25.3 | 22.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 8.2 | 27.6 | 23.5 | 18.8 | 16.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.96 | 21.8 | 19.6 | 14.9 | 7.18 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 6.18 | 22.7 | 19.7 | 16.2 | 9.33 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.18 | 22.7 | 19.7 | 16.2 | 9.33 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.97 | 1.45 | 4.46 | 3.68 | 2.13 |
Dividends per Share |